Directory · PL
Biotechnology Research in Poland
A register of firms and the professionals working at them in the Biotechnology Research sector based in Poland. Browse the public index, then filter or export on Kipplo.
Companies
232 on file
Warsaw Society Of Biotechnology Symbioza
Warsaw Society of Biotechnology (WSB) “Symbioza” was founded in 2013 on the basis of the collaboration between students and graduates of the three most important universities in Warsaw: University of Warsaw, Warsaw University of Technology and Warsaw University of Life Sciences. Our aim is to integrate the biotechnology environment in Poland starting from the youngest generations, and promotion and popularization of biotechnology in this part of Europe. We make it happen through a bunch of project such as Intercollegiate Symposium of Biotechnology "Symbioza", workshops on the art of scientific presentation called "OAK", and FeelTheFlow science-popularization meetings. Our projects-INTERCOLLEGIATE BIOTECHNOLOGY SYMPOSIUM -ATTRACTIVE CONVENTICLES CAMP -FEEL THE FLOW PROJECT And many more.
51 to 200 staff
Wpd Pharmaceuticals Sp. Z O.O
WPD Pharmaceuticals is a Polish biotech company developing innovative oncology therapies for high-mortality cancers. While initially focused on lethal brain tumors like glioblastoma, WPD has built a diverse pipeline of patented drug candidates (licensed from Wake Forest University) including cutting-edge antibody-drug conjugates. Our flagship ADC, WPD401, co-developed with Wake Forest, uniquely targets four tumor-specific receptors (IL-13Rα2, EphA2, EphA3, EphB2) found in some of the toughest-to-treat cancers. Originally designed for glioblastoma, WPD401 has shown potent activity in other aggressive tumors that overexpress these receptors – for example, triple-negative breast, pancreatic, and certain lung cancers – thereby broadening its clinical potential into multiple high-need indications. Backed by this innovative multi-target approach and encouraging preclinical results, WPD is now advancing toward clinical trials in the United States. We are actively seeking strategic partners to co-develop and unlock the full potential of our pipeline, with the aim of delivering life-changing therapies for patients with limited treatment options. The controlling shareholder of WPD Poland is ACRX Investments Limited.
11 to 50 staff
Biocam
We are an innovative technology company, we develop medical technologies that increase the comfort of patients’ lives and allow to improve the health care system. Our advanced technologies allow for non-invasive and accurate capsule endoscopy examinations. BioCam technology is based on AI solutions and advanced electro-optics.
11 to 50 staff
Koppert Polska
Naturalne, bezpieczne rozwiązania poprawiające zdrowie, odporność i produkcję roślin uprawnych. Zapylanie roślin.
11 to 50 staff
Vaxican
VAXiCAN, pre-clinical stage biotechnology company with vision to create Next Generation Immunotherapeutics, develops unique novel platform of therapeutic cancer vaccines based on proprietary enveloped virus-like particles (Enveloped VLPs), which provide the safest and most effective way of instructing and strengthening the Patient's anticancer defense mechanisms. VAXiCAN VLP platform is widely supported by fully owned and in-house developed novel dedicated proprietary elements of machine learning (ML) and artificial intelligence (AI). The path chosen by the VAXiCAN is the use of naturally occurring or genetically modified oncolytic viruses using an innovative antigen delivery method using insect models (most similar solutions use mammalian, fungal or completely synthetic models). VAXiCAN VLP vaccines are designed to present the extracellular domains of cancer antigens while leveraging the immune system's mechanism to mimic viral infection, thereby enhancing antigen presentation through the recognition of pathogen-associated molecular patterns (PAMPs). This strategy not only stimulates a strong adaptive immune response characterized by the production of high-affinity antibodies and cytotoxic T cells crucial for targeting tumor cells, but also actively engages natural killer cells supported by memory cells. First pre-clinical lead candidates are addressing HER2 and GD2 cancers, incl. breast cancer, neuroblastoma, melanoma as well as HPV/HBV-related cancers with potential of at least two first-in-class drug candidates and at least one in the orphan drug and fast track regulatory designations. VAXiCAN also operates in the field of modern whole viral and protein sequencing acting as Oxford Nanopore certified partner. We specialize in bioinformatic analysis of full genomes of microorganisms, including bacteria, bacteriophages, human and animal viruses as well as full human genomes.
1 to 10 staff
Nomi Biotech Corporation
Nomi Biotech Corporation is a Polish-Japanese biotechnology company co-financed by the National Centre for Research and Development. Our company specializes in selection, research and manufacturing of proprietary and clinically potent nutraceutical formulations of plant origin. We are a leading CRO organization in Poland specializing in pre- and clinical stage research and trials of nutraceuticals. Our core scientific team is made up of medical doctors, molecular biologists and cytogeneticists with extensive expertise and experience in medical practice and innovative R&D projects.
11 to 50 staff
Allergen Centrum Medycyny Spersonalizowanej
Jesteśmy pionierem w diagnostyce molekularnej alergii, badaniu mikrobioty jelitowej i markerów stanu zapalnego jelit, wykrywaniu zakażeń pasożytniczych, kompleksowej diagnostyce boreliozy oraz analizie mutacji genowych – identyfikacji markerów nowotworowych, chorób i predyspozycji genetycznych oraz genetycznej diagnostyce poronień nawracających i niepłodności immunologicznej. Centrum Medyczne AllerGen skupia najlepszych specjalistów z dziedziny alergologii, pediatrii, immunologii, dietetyki klinicznej, dermatologii, reumatologii, genetyki, parazytologii i chorób wewnętrznych. Zajmujemy się diagnostyką i leczeniem wszelkich chorób alergicznych, schorzeń jelit, zakażeń pasożytniczych, boreliozy oraz chorób o podłożu autoimmunologicznym i genetycznym. Współpraca lekarzy z dietetykami klinicznymi oraz specjalistami mikrodżywiania, analityki i biotechnologii medycznej jest kluczem do zapewnienia naszym pacjentom kompleksowej opieki. Korzystamy z najnowszych badań naukowych, doświadczeń klinicznych oraz nowoczesnej diagnostyki. Naszą misją jest również działalność dydaktyczno-naukowa, edukujemy kadry medyczne aby nieustanie zwiększać świadomość i dostęp do innowacyjnych narzędzi diagnostycznych oraz nowych, potwierdzonych badaniami form terapii.
11 to 50 staff
Futuresynthesis
FUTUREsynthesis is a privately held company specializing in biomolecules synthesis on customer's demand. We synthesize RNA and DNA sequences on scale from 0.1 to 10 umoles up to 75 and 150-mers respectively. We offer a wide range of modifications including modified nucleosides (i.e. 2’-O-Me, 2’-F, 8-oxodG, dU, inosine), fluorescence-labelled sequences, cystamine, thiol SS-C6 linker and oligonucleotide triphosphates. We provide assistance in solving of chemical problems in biotechnology and synthesis of complex compounds.
1 to 10 staff
Human Biome Sa
The Human Biome was established as a Medical University of Warsaw spin-off due to the commercialization of our scientific research. Initially at the University, then at the Human Biome, in close cooperation with academia, since 2014, we conduct research on the gut microbiome as a new type of biotherapeutic agent. Having very rich baggage of experience in hematology, transplantation, immunology, and microbiology, we have combined many fields of medicine and technology to enter the world of the microbiome and discover what is undiscovered. HBI combines highly innovative microbiome knowledge and breakthrough technologies in one unique approach that is able to generate a pipeline of donor-independent New Generation Biotherapeutics (NGBs) as a Live Biotherapeutics Products (LBPs). Technologies and microbiome products developed by HBI: 1. “MicroDrug®” - AI/ML-based in-silico and ultra-deep tech in-vitro lab composing Drug Discovery Platform to predict microbiota-based drugs-"Trapp MIcroBS"- in-silico computational platform predicting drug compositions - “Q Lab” - highly innovative in-vitro laboratory applying microfluidic, genomic, culturomic and robotic technologies to synthesize New Generation Biotherapeutics. Microbiome Biobank - over 20 samples collected to date, from unique donors and patients (triads) treated by in-house produced highly rich and viable microbiota transplant preparations (Mbiotix) 3. Fecal Microbiota Transplantation (FMT) Facility with Clinical Platform (HBI leads 8 clinical experiments based on FMT to discover context-oriented drug compositions) 4. “Mbiotix” - highest-quality FMT preparation delivered to over 1400 patients. Currently, in the HBI pipeline are developed 4 New-Generation Biotherapeutics (NGB)- anti-CDI NGB (anti Clostridioides difficile NGB)- flagship anti-ARB/AI NGB (anti-antibiotic resistant bacteria and anti-infective NGB)- immunobooster NGB (GvHD and immunooncology)- longevity/wellbeing NGB.
11 to 50 staff
Insignes Labs
At Insignes Labs, we create innovative and eco-friendly solutions — including fertilizers and biostimulants — that empower farmers across the globe. Our technologies help reduce the reliance on chemical pesticides and synthetic fertilizers, all while maintaining high crop yields. We believe that sustainable agriculture is the future, and we’re proud to support farmers in growing healthier, more resilient plants. By improving plants & soil health we are boosting crop quality, we help deliver better food from field to table.
1 to 10 staff
Novilet Llc
Novilet is a developer of high-tech laboratory devices based on the Electron Paramagnetic Resonance phenomenon. We focus on the classical low-frequency EPR spectroscopy and we develop a new approach to EPR imaging. We offer the solution dedicated to low-frequency EPR spectroscopy. What makes our device so special is much better sensitivity and the possibility of using lower concentrations of the spin probes (on the contrary to the existing systems). We also solved the problems with the limited sample size, with our spectrometer you can measure in-vivo objects ranging from fish embryos, mice up to a small rabbits. Our second flagship-product is the ERI tomograph, that allows performing dynamic measurements of the microenvironment parameters. Electron Resonance Imaging is a preclinical imaging method that can be applied to a broad range of research in the areas of oncology, neurodegeneration, biology and many more. The ERI TM 600, as the world’s only scanner, enables the whole-body 3D imaging of oxygen levels, redox state, oxidative stress, ROS and pH in living organisms.
11 to 50 staff
Biobest Polska
Biobest, we invented the buzziness As a pioneer in the production of bumblebees since 1987, Biobest has become one of the world’s leading companies in natural pollination and biological control of pests and diseases. Known since many years for its bumblebees and wide range of beneficial insects, mites and nematodes, the company now offers a complete range of natural solutions including biopesticides, monitoring and scouting tools, pheromones …. With 28 group companies in 6 continents, distributors in more than 65 countries and over employees worldwide, we stand prepared to provide growers with tailor-made advice. We focus on vegetables, ornamentals, soft-fruits and orchards. With the power of our natural solutions, a successful crop goes hand in hand with a healthy product and a clean environment. Your crop deserves the best! info@biobestgroup.com +48 61 899 83 77
1 to 10 staff
Ekolab
Ekolab Sp z o.o. mający swoją siedzibę w Kobylicy pod Poznaniem, świadczy usługi w dziedzinie ochrony środowiska. W naszych nowocześnie wyposażonym pracowniach i akredytowanym laboratorium przeprowadzamy badania środowiskowe, w tym analizy wody, ścieków, odpadów i wiele innych. Wykonujemy również pomiary akustyczne, pomiary wentylacji i pomiary środowiska pracy.
11 to 50 staff
Amplicon Sp. Z O.O
Our purpose is to propagate new technologies based on DNA sequence (real time PCR) in several areas such as: medical and veterinary diagnostics, food and feed industry, quality control of drinking water, pharmaceutics. We realize these goal by:(1) development of diagnostic tests based on the information saved in the DNA sequence;(2) development of diagnostic and research methods allowing for use of the genetic information in medicine, veterinary and various areas of the industry. We offer- tests and kits dedicated for detection of microorganisms (bacteria, protista and viruses) dangerous for health and live of humans and animals- tests for detection of GMO varieties in foods and forages- tests for diagnosis of genetic diseases or predispositions- additional materials used by laboratories for validation of diagnostic methods (e.g. genomic DNA of pathogenic bacteria).
1 to 10 staff
Arthec S.A
ArThec is a medical biotechnology company specializing in tissue engineering and regenerative medicine. We focus on developing Advanced Therapy Medicinal Products (ATMPs) and innovative medical devices that support our transformative therapies. At the heart of our approach is Pearl Technology, a proprietary, cutting-edge platform designed to regenerate damaged cartilage and restore joint function. The Pearl procedure enables the complete regeneration of cartilage, offering a durable, long-term solution for joint degeneration. By harnessing the power of advanced tissue engineering, we help patients maintain their natural, fully functional joints for a lifetime, reducing the need for invasive surgeries and improving quality of life.#JointHealth #Osteoarthritis #LifeUninterrupted #RegenerativeMedicine #WeRestoreMobility
1 to 10 staff
I.C.Lab
Dostarczamy urządzenia dla jednostek naukowych z branży Life Science, sami posiadając laboratorium mikroskopii superrozdzielczej, w którym świadczymy usługi obrazowania STED.
1 to 10 staff
Institiute Of Molecular Diagnostic Diagmol
We can cure every disease that is early detected. Whole Exom Sequencing (WES) can help to detect and describe probability of appearance any gen-based disease.
1 to 10 staff
Pioligon
VPDesigner42™ is a powerful drug discovery platform leveraging the latest advances in computational de novo peptide design and unnatural peptide synthesis.
1 to 10 staff
Sknfm Kerma
Koło naukowe SKNFM KERMA, działające przy Wydziale Fizyki i Informatyki Stosowanej zrzeszające pasjonatów Fizyki medycznej.
11 to 50 staff
Cruxbio
Comprised of highly-skilled scientists and engineers, we bring a diverse range of expertise to the table. Our team includes experts in biology, bioinformaticians, molecular biologists, and biotechnologists, as well as specialists in cloud computing, data science and AI/ML solutions. We have extensive experience in analyzing big data, such as whole genome sequencing, NGS panels, RNAseq and real-world evidence data. We tackle complex and demanding projects to provide our clients with highly valuable insights.
1 to 10 staff
Pti Life Sciences Sp. Z O.O
We are a biotech company dedicated to enhancing the health and well-being of both people and animals. We firmly believe in providing everyone with access to healthcare, ensuring that all individuals have the opportunity for a better quality of life.
1 to 10 staff
Dumpling
Dumpling is a multi-purpose NMR platform that accelerates all aspects of spectra analysis. To this end we employed cutting edge technologies, e.g. Machine Learning, Computer Vision, JAVA. Dumpling as a platform was built from scratch but, to allow users’ fast adaptation to it, we introduced a Sparky-like GUI, which is the most popular software in the NMR community. Besides the user-friendliness of Sparky, Dumpling features high-performance multidimensional spectra display, deep learning-assisted automated peak picker, smart guides speeding up sequence-specific resonance assignment, scientific figure preparation suite, integration with CYANA, 1D spectra display and analysis, automated peak tracking in titration experiments and many more.
11 to 50 staff
Gentaur Genprice Group
We are located in: USA, UK, BE, FR, GE, IT, NL, PL, BG • We offer 100 of different brochures for your projects. • You can discuss your custom projects. • Show us your results for technical support. • We will help you choose your products - You can take them to your lab the same day! • We have a lot of free samples available to test. • If you have ideas for new products we are interested in discussing distribution condition
51 to 200 staff
Orthoget
We are a bioengineering company and conduct R&D projects in the area of implantology. We help people with lower-limb asymmetry and short stature.
1 to 10 staff
Skotan S.A
Skotan S.A. to spółka giełdowa z wieloletnią tradycją o 100% kapitale polskim. Na bazie polskiej myśli naukowej i wypracowanych patentów działa w segmencie nowych innowacyjnych technologii. Wychodząc naprzeciw codziennym wyzwaniom dzisiejszego świata dostarcza rozwiązania podnoszące standard życia, zdrowia oraz poprawiające funkcjonowanie organizmu. Misją spółki jest kreowanie zdrowego trybu życia poprzez dostarczanie najwyższej jakości składników odżywczych. Wysoce wykwalifikowana kadra spółki Skotan każdego dnia pracuje nad rozwiązaniami wspierającymi zdrowie, rozwój oraz szeroko pojętą profilaktykę. Unikalne rozwiązania technologiczne zapewniają najwyższy standard i jakość wytwarzanych produktów aby wyjść naprzeciw potrzebom każdego z nas.
11 to 50 staff
Spawnfoam
Spawnfoam® is a biotech company for the development of biocomposites, using materials of lignocellulosic origin and other by-products of the forestry and agroindustrial sectors.
1 to 10 staff
Spinbionic
Celem SpinBionic jest zarówno komercjalizacja wyników prac badawczych prowadzonych w ramach działalności naukowej jak i oferowanie specjalistycznych usług z zakresu badań in vitro, inżynierii tkankowej, biodruku 3D, produkcji białek oraz szeroko pojętej biotechnologii medycznej i biologii molekularnej.
1 to 10 staff
Greenland Technologia Em Sp. Z O.O
Greenland Technologia EM zajmuje się produkcją i sprzedażą produktów opartych o technologie Efektywnych Mikroorganizmów znajdujących bardzo szerokie zastosowanie w rolnictwie i ogrodnictwie, hodowli zwierząt, czy w biologicznym oczyszczaniu środowiska. Coraz częściej Technologia EM wykorzystywana jest także bezpośrednio do użytku domowego w postaci środków myjących, odświeżaczy powietrza, kosmetyków a także jako suplementy diety służące do odbudowywania właściwej mikroflory. Zakład produkcyjny firmy ulokowany jest na Lubelszczyźnie, koło Janowca. Firma Greenland Technologia Em Sp. z o.o. jest wyłącznym licencjobiorcą EMRO na Polskę i Europę Środkowo-Wschodnią. EMRO jest też licencjodawcą dla producentów i dystrybutorów produktów do kilkudziesięciu krajów na wszystkich kontynentach. Firma Greenland od początku swojej działalności stawia sobie za cel propagowanie wiedzy na temat naturalnych metod dbania o środowisko, udowadnia, że stosowanie naturalnych mikrobiologicznych metod może iść w parze z ekonomicznym sukcesem.
11 to 50 staff
Orphinic Scientific
Orphinic Scientific S.A. was funded in 2019 as the first Polish biotech portfolio platform creating innovative solutions for orphan diseases and other indications with significant unmet medical needs in the clinical trial phase. Orphinic core scientific team consist of experts with over 20 years experience in clinical development processes and their commercialization. The company’s competencies in clinical stage development are further enforced through a collaboration with a large clinical CRO operating in the CEE region. This facilitates access to diverse patient populations and rapid enrollment to clinical trials supporting our projects and significantly shortens the duration of individual phases. Orphinic currently has 11 projects in the pipeline that range from a preclinical phase to market approval stages in three healthcare segments: therapeutics, medtech and e-health. ⏱ We shorten time to the market due to specialized healthcare centers in CEE and an affiliated CRO. 🩺 Our team has an exceptional track record in sourcing and exiting high-quality projects. 🧬 Our portfolio represents clinic-ready assets, with first projects ready to exit in 2023, and a preclinical pipeline for long-term value creation. We invest in projects with low correlation. Average project risk of c.50% with average returns of c.10x our investment. Our plan is to IPO at Warsaw Stock Exchange by the end of 2022.
11 to 50 staff
Biotech Horizons
We build a community of young, ambitious, entrepreneurial students by enabling them connection to the world of business and science.
11 to 50 staff
Biowood Energia Sp.Z.O.O
Biowood Energy – biomass producer. We are passionate and experienced people, who are always happy to answer any question or advise due to supply heat to every building that has a pellet stove. Wood pellet is a biofuel with a responsible approach to natural resources and environmental protection, as well as our health and convenience. Biowood Królewski Pellet is a high-quality, repeatable product for demanding clients who are aware of the benefits of complete kiln firing and cleanliness in storage.
201 to 500 staff
Ecomyko
ecomyko is an impact organisation dedicated to maximising the value of plastics at the end of their life cycle, helping to avoid CO₂-emitting incineration. By leveraging fungal enzymes, we transform plastic waste into valuable, eco-friendly products such as biodegradable packaging, insulation, and acoustic panels. Our innovative approach fosters a circular economy while reducing the environmental impact of plastic waste. In collaboration with waste management companies and brands, we aim to create sustainable solution that benefit both the planet and the waste management industry.
1 to 10 staff
Astroglial Innovations
We bring back motor and sensory functions to patients with spinal cord injuries by engaging advanced tissue engineering and neurosurgery solutions.
1 to 10 staff
Biocentrum Sp. Z O.O
BioCentrum's mission is to create a platform for our clients and partners in order to help them translate innovative discoveries into preclinical candidates with improved chances to become marketed in the least amount of time possible. Our offer is a range of in vitro and in vivo assays that are created toward incorporating preclinical information into your pipeline.
11 to 50 staff
Phage Consultants
At Phage Consultants, we are world experts on bacteriophages, the distinctive ‘legged’ viruses that infect bacteria. First discovered around 1915, bacteriophages (or ‘phages) play several important roles in viral biology. Not only do they contaminate bacterial and biological processes but can also be used to kill other bacteria that are contaminants. Phages have also been used to elucidate DNA viral reproduction through lytic and lysogenic cycles and, for the past 100 years, as alternatives to antibiotics, with therapeutic effects against multi-drug-resistant strains of many bacteria. Based in Gdansk, Poland, Phage Consultants specializes in bacteriophage detection and characterization and production as a contract research and manufacturing organization. We have become world leaders in using the power of bacteriophage technology in bioprocess infection and contamination control and assisting companies whose production is based on microbial activities in preventing bacteriophage contamination, along with bacterial, fungal and viral contaminations. We also specialize in the field of bacteriophage biology with specific expertise on phage activity in bioprocessing. We can provide unique assistance to pharmaceutical and biotech companies, offering a range of services from personal training to consulting and process optimization in phage growth limitation as well as advising on development of contamination-resistant bioprocess facilities.
1 to 10 staff
Target Cells
Target Cells is a biotech startup founded by scientists from Poland and the USA, specializing in stem cell research for cardiac regeneration applications. Backed by Medi Ventures (Poland) and Chicago Poland Ventures (USA), we develop targeted stem cell-based therapeutics for myocardial repair to address cardiovascular diseases - the leading cause of death globally. Our Achievements- Holder of 2 patent applications: European (2024) and PCT (2025)- Successfully delivered 1M PLN EU-funded R&D project, resulting in a prototype of a breakthrough in vitro diagnostic assay enhancing the efficacy of stem-cell based therapies for cardiac regeneration - Winner of "Innovation Voucher" R&D grant from Małopolska Centre for Entrepreneurship - Top performer at FENG's 2024 Smart Track (scored 23/25 points)- Strategic partnerships with leading institutions incl. Jagiellonian University in Krakow We aim to commercialize innovative products for targeted stem cell delivery in cardiac applications, transforming regenerative medicine and improving patient outcomes worldwide.
1 to 10 staff
Biovectis
BioVectis (c/o K.Kucharczyk Techniki Eletroforetyczne Spzoo) is developing, manufacturing and marketing life sciences R&D tools for a scientific and medical diagnostic market in Poland and EU. We are active across different technology sectors like medicine, veterinary, molecular biology up to electronics. The new products are developed in collaboration with research organizations and SME from Poland, EU and US. For our actual products portfolio please refer to Oure R&D projects Drug discovery projects: • Appus – microRNA and peptides autoimmune diseases treatment candidates validate in vivo Veterinary • ScutumN - recombinant viral vaccine against Newcastle Disease virus for poultry Medical diagnostics • Vela – voltaic organic compounds diagnostics POC platform • AgePlex – biological age estimation kit based on the epigenetic markers Life Sciences R&D tools • MSSCP - minor genetic variants discover and validation platform (Onco & Virology) • DNAPointer System – protein-protein and protein-nucleic acids interaction analysis • Lacerta_C method, equipment and kits for the efficacy of DNA repair mechanism evaluation
1 to 10 staff
Dermomedica Group Sp. Z O.O
Dermomedica Group is a polish brand with an American DNA. Our philosophy is to provide cosmetologists, patients, physicians, aestheticians with innovative, results driven, skincare solutions. Using unparalleled and unique professional formulations, we are happy to provide the highest quality in skincare practices. We are certified and exclusive distributor of Dermaquest brand on the polish beauty market. Our private label brands: Dermomedica Cosmeceuticals, Dermo Care and Nanofrax gained traction in the beauty & medical industry.
11 to 50 staff
Ascentia
Ascentia is a science-driven biotechnology company and integrated CRO partner, specializing in the discovery and development of small-molecule therapeutics. As a contract research organization, we collaborate with biotech, pharma, and academic teams by offering flexible, end-to-end support in medicinal chemistry (including computer-aided drug design), synthetic chemistry,biology, biochemistry and biophysics. Our internal R&D concentrates on underexplored areas of biology, with a special focus on modulation of transmembrane receptors that provide novel opportunities for therapeutic intervention. Whether advancing internal pipelines or supporting client programs, Ascentia delivers high-impact solutions tailored to modern R&D sector requirements.
1 to 10 staff
Bacteromic
Bacteromic Sp. z o.o. is a part of the Scope Fluidics Group and was established to develop the BACTEROMIC system, used to assess the drug susceptibility of microorganisms. The BACTEROMIC system enables phenotypic evaluation of the efficacy of antibiotics, used to treat infections of the respiratory system, blood, urinary tract, skin, and other areas. It also has the capability to detect resistance mechanisms. Thanks to the determination and expertise of a multidisciplinary team of biotechnologists, engineers and software developers, and their innovative approach to modern diagnostics, this device holds significant market potential and the ability to revolutionize antibiotic treatment.
11 to 50 staff
Biotechnology Student Association Ferment
Research projects. Academic, cultural, and social events for the student and local communities. Science popularization.
51 to 200 staff
Bio-Mar Diagnostics
Since 2001 Bio-Mar Diagnostyka has been distributing medical devices for "in vitro" diagnostics to both business and individual customers. It is an authorized representative of leading manufacturers such as Aesku.Diagnostics, Mediwiss Analytic GmbH, Institut Virion \ Serion GmbH, Spinreact, Biotecnica, Teco GmbH, Diamond Diagnostics CORP and Seramun Diagnostica GmbH. Our mission is based on the belief that diagnosis is the first and most important element of disease monitoring, prevention and treatment. That is why BIO-MAR Diagnostyka has been offering its clients not only the highest quality products for 20 years, but also professional consulting in the field of diagnostic services based on many years of experience. The BIO-MAR Diagnostyka team consists of professionals for whom giving customers a sense of security is a priority in this profession.
11 to 50 staff
A-Biotech Sp. Z O.O
Firma A-BioTech oferuje kompleksowe wyposażenie laboratoriów, w aparaturę naukowo-badawczą i odczynniki.
1 to 10 staff
Bhumi
BHUMI (Biological Healthy & Unique Microbial Innovations)
1 to 10 staff
Biogenies
We are a dynamic team of passionate individuals driven by a collective vision of advancing scientific discovery. With diverse backgrounds and interests, we form a vibrant community dedicated to exploring a vast array of topics spanning the realms of molecular biology, amyloids, antimicrobial peptides, predictive models, database construction, and cutting-edge advancements in machine learning and artificial intelligence. Our collaborative efforts blend expertise from various disciplines, fostering innovative approaches and breakthroughs at the intersection of science and technology.
1 to 10 staff
Dna Medical Group Sp. Z O.O
Jesteśmy Polskim laboratorium genetycznym, zlokalizowanym w Łodzi na ul. Niciarnianej 49. Swoją działalność opieramy na najwocześniejszym sprzęcie do sekwencjonowania firmy MGI. Sekwencjonowanie nowej generacji (NGS) stosowane w naszych sekwenatorach rozwijane jest od ponad 20 lat. Metoda ta została zastosowana w niezliczonej liczbie projektów, dzięki czemu została doprowadzona niemalże do perfekcji. Ogromne doświadczenie naszego zespołu pozwala nam zaproponować optymalną dla każdego metodologię sekwencjonowania umożliwiającą uzyskanie najlepszych wyników sekwencjonowania.
11 to 50 staff
Modica
MODICA provides equipment and engineering services for biotechnology, bioprocess, biomanufacturing, and pharma industry. We are specialists in modular novel lab equipment and both downstream & upstream process development. http://modica.bio/ We offer a practical approach and flexible solutions tailored for the particular needs of a project and company.
1 to 10 staff
Medical Inventi S.A
Medical Inventi S.A. is an innovative biotechnology company founded in 2015, created on the initiative of the academic community of the Medical University of Lublin and private capital. We specialise in the development and production of biomaterials that find applications in orthopaedics, dentistry and veterinary medicine. Our products, available under the brand names FlexiOss®, FlexiOss®Dent and FlexiOss®Vet, are the result of many years of research trials and experience, and their effectiveness has been confirmed in numerous studies.
1 to 10 staff
